Bemitil plus carnitine: asthenia and fatigue claims — RU2578412C1
Аллан Герович Бениашвили, Маргарита Алексеевна Морозова · 2016 · RU2578412C1 · patent family 55656639
Published 2016-03-27.
Reported patent results
Reported findings
The combination improved some fatigue- and depression-like behaviors, while episodic-memory testing was neutral.
Repeated-stress mouse experiments comparing Bemitil, levocarnitine and their combination; not a human ME/CFS trial.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Physical-fatigue tasks | Combination reportedly reduced fatigue in swim and rotating-rod tests at a selected tested combination | Exact mean differences not transcribed; individual drugs and combinations differed |
| Depression-like behavior | Reduced stress-associated immobility reported across tested combination exposures | Behavioral proxy, not clinical depression recovery |
| Episodic memory | No detected effect of the tested substances; stress itself did not significantly impair this endpoint | Control preference index 67.7 ± 4.4%; neutral treatment result retained |
Animal stress tasks and a combination do not establish Bemitil monotherapy, ME/CFS benefit or synergy. A neutral memory test cannot be rephrased as cognitive improvement.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Formulation. The filing describes ethylthiobenzimidazole hydrobromide combined with carnitine for proposed fatigue-related applications.
This is a combination, not Etomerzol and not a demonstration of Bemitil monotherapy efficacy in ME/CFS.
- Publication
- RU2578412C1 ↗ · 2016-03-27
- Earliest priority / filing
- 2014-12-02 / 2014-12-02
- Original applicant / assignee
- Общество С Ограниченной Ответственностью "Валента - Интеллект"
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 55656639 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Pharmaceutical composition for treating asthenia and/or chronic fatigue syndrome
Inventors: Аллан Герович Бениашвили; Маргарита Алексеевна Морозова.
RU2578412C1 · KR101942205B1 · CN107205944A · EA027170B1 · UA112719C2 · WO2016089251A1
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- This is a combination, not Etomerzol and not a demonstration of Bemitil monotherapy efficacy in ME/CFS.
- Animal stress tasks and a combination do not establish Bemitil monotherapy, ME/CFS benefit or synergy. A neutral memory test cannot be rephrased as cognitive improvement.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-55656639. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Аллан Герович Бениашвили, Маргарита Алексеевна Морозова. Bemitil plus carnitine: asthenia and fatigue claims — RU2578412C1 RU2578412C1 · patent family 55656639 2016.
Molekul research summary: https://molekul.io/research/patent-ru2578412c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry